XNYS
VTR
Market cap39bUSD
Oct 08, Last price
81.76USD
1D
2.15%
1Q
-9.82%
Jan 2017
30.77%
Name
Ventas Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ventas, an S&P 500 listed enterprise, occupies a distinctive position at the convergence of the healthcare and real estate industries. As a globally recognized leader among Real Estate Investment Trusts (REITs), the company strategically deploys its financial resources to enhance the inherent value of its property assets. Ventas cultivates strong alliances with prominent care providers, innovative developers, leading research and medical institutions, and other healthcare organizations, all of whom benefit from the significant market driver of an aging global demographic. For over two decades, Ventas has pursued a consistent and effective operational framework. This strategy involves building a high-quality, diverse portfolio of properties complemented by various capital sources, enabling the company to successfully navigate economic fluctuations. Ventas emphasizes collaborative engagements with industry-leading partners and relies on an experienced, unified team focused on generating stable, growing cash flows and superior returns for its shareholders, all supported by a robust balance sheet. As of September 30, 2020, Ventas's extensive holdings included approximately 1,200 properties, either directly owned or managed through unconsolidated joint ventures.
Related entities
Subsidiaries (34)
LS UCITY ACADEMIC REIT, LLC
LS UCITY ACADEMIC UT, LLC
NHP BLACKSTONE LLC
NHP CHESTNUT HILL LLC
NHP HARWICH LLC
NHP MELBOURNE LLC
NHP NORTON LLC
NHP SHARON LLC
NHP WESTON LLC
Ventas SSL Holdings Finance, LLC
Ventas UK II, LLC
VTRAZ SACRAMENTO, LP
WE 100 COLLEGE STREET LLC
WEXFORD-UCSC 3737, LLC
Key people
Chief Financial Officer, Executive Vice President · since 2015
Peter J. Bulgarelli
Executive Vice President and President and Chief Executive Officer, Lillibridge Healthcare Services, Inc. · since 2018
John D. Cobb
Executive Vice President, Chief Investment Officer · since 2013
Chairman of the Board, Chief Executive Officer · since 2010
Jay M. Gellert
Independent Director · since 2001
Independent Director · since 2011
Roxanne M. Martino
Independent Director · since 2016
Independent Director · since 2019
Independent Director · since 2016
Robert D. Reed
Independent Director · since 2008
Presiding Independent Director · since 2016
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
500 Hurstbourne Parkway
Suite 200
Louisville, KY 40222
US
Suite 200
Louisville, KY 40222
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||